| Epiphany Medical Services, Pc | |
|
2440 Whitney Ave Hamden CT 06518-3222 | |
| (203) 389-5606 | |
| Not Available |
| Full Name | Epiphany Medical Services, Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 2440 Whitney Ave, Hamden, Connecticut |
| Authorized Official Name and Position | Paul Kevin Clarke (DIRECTOR/OWNER) |
| Authorized Official Contact | 2033895606 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Epiphany Medical Services, Pc 531 Overland Dr Orange CT 06477-2655 Ph: (203) 492-9395 | Epiphany Medical Services, Pc 2440 Whitney Ave Hamden CT 06518-3222 Ph: (203) 389-5606 |
| NPI Number | 1356840466 |
|---|---|
| Provider Enumeration Date | 02/04/2018 |
| Last Update Date | 03/06/2019 |
| Medicare PECOS PAC ID | 0547503559 |
|---|---|
| Medicare Enrollment ID | O20190515000091 |
News Archive
Although it is "easy to hoot with derision" at the "awfully complicated positions" on abortion rights taken by former New York City Mayor Rudolph Giuliani (R) and former Massachusetts Gov. Mitt Romney (R), the two possible Republican presidential candidates "make sense" when listened to "with a decent sympathy," Ann Althouse, a law professor at the University of Wisconsin, writes in a New York Times opinion piece.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.
State public health departments do not necessarily lose funding when merged with larger Medicaid programs, according to a just-released study. The findings from this first-of-a-kind research should help allay concerns that when such mergers occur they automatically lead to cutbacks in public health, says lead author Paula Lantz, PhD, who is chair of the Department of Health Policy at the George Washington University School of Public Health and Health Services (SPHHS).
Emerald BioStructures today announced a three-year extension of its ongoing collaboration with UCB. The strategic aspects of this renewed relationship will provide Emerald with research funding over the three-year period and the opportunity to receive milestones and royalties on future drug product revenues.
Using positron emission tomography (PET) imaging of the brain, researchers have identified a sweet spot that operates in a disorderly way when simple sugars are introduced to people with insulin resistance, a precursor to type 2 diabetes.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356840466 | NPI | - | NPPES |
| 001390385 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Paul K Clarke |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548292279 PECOS PAC ID: 0143412197 Enrollment ID: I20101008000166 |
News Archive
Although it is "easy to hoot with derision" at the "awfully complicated positions" on abortion rights taken by former New York City Mayor Rudolph Giuliani (R) and former Massachusetts Gov. Mitt Romney (R), the two possible Republican presidential candidates "make sense" when listened to "with a decent sympathy," Ann Althouse, a law professor at the University of Wisconsin, writes in a New York Times opinion piece.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.
State public health departments do not necessarily lose funding when merged with larger Medicaid programs, according to a just-released study. The findings from this first-of-a-kind research should help allay concerns that when such mergers occur they automatically lead to cutbacks in public health, says lead author Paula Lantz, PhD, who is chair of the Department of Health Policy at the George Washington University School of Public Health and Health Services (SPHHS).
Emerald BioStructures today announced a three-year extension of its ongoing collaboration with UCB. The strategic aspects of this renewed relationship will provide Emerald with research funding over the three-year period and the opportunity to receive milestones and royalties on future drug product revenues.
Using positron emission tomography (PET) imaging of the brain, researchers have identified a sweet spot that operates in a disorderly way when simple sugars are introduced to people with insulin resistance, a precursor to type 2 diabetes.
› Verified 5 days ago
News Archive
Although it is "easy to hoot with derision" at the "awfully complicated positions" on abortion rights taken by former New York City Mayor Rudolph Giuliani (R) and former Massachusetts Gov. Mitt Romney (R), the two possible Republican presidential candidates "make sense" when listened to "with a decent sympathy," Ann Althouse, a law professor at the University of Wisconsin, writes in a New York Times opinion piece.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.
State public health departments do not necessarily lose funding when merged with larger Medicaid programs, according to a just-released study. The findings from this first-of-a-kind research should help allay concerns that when such mergers occur they automatically lead to cutbacks in public health, says lead author Paula Lantz, PhD, who is chair of the Department of Health Policy at the George Washington University School of Public Health and Health Services (SPHHS).
Emerald BioStructures today announced a three-year extension of its ongoing collaboration with UCB. The strategic aspects of this renewed relationship will provide Emerald with research funding over the three-year period and the opportunity to receive milestones and royalties on future drug product revenues.
Using positron emission tomography (PET) imaging of the brain, researchers have identified a sweet spot that operates in a disorderly way when simple sugars are introduced to people with insulin resistance, a precursor to type 2 diabetes.
› Verified 5 days ago
David M. Stevenson Aprn Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 215 Sherman Ave, Hamden, CT 06518 Phone: 203-288-6800 Fax: 203-287-1953 | |
Hamden Medical Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2340 Whitney Ave, Hamden, CT 06518 Phone: 203-248-8142 Fax: 203-248-7764 | |
Gastroenterology Center Of Connecticut, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2200 Whitney Ave, Suite 360, Hamden, CT 06518 Phone: 203-281-4463 Fax: 203-287-2914 | |
Margaret Chustecka Internal Medicine Of Greater New Haven Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1952 Whitney Ave, Hamden, CT 06517 Phone: 203-848-1803 Fax: 203-848-1777 | |
Express Care Urgent Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1650 Dixwell Ave, A, Hamden, CT 06514 Phone: 203-288-1700 Fax: 203-859-5392 | |
Whitney Internal Medicine Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2440 Whitney Ave, Hamden, CT 06518 Phone: 203-288-9650 Fax: 203-288-9670 | |
Imfp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2447 Whitney Ave Ste 2a, Hamden, CT 06518 Phone: 203-230-5888 Fax: 203-230-5889 |